Search Within

Gnana Prakasam Krishnamoorthy

Formats
  1. Journal Article (14)
  2. Meeting Abstract (3)
  3. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (18)
  2. Department of Medicine (18)
  3. Division of Subspecialty Medicine (18)
  4. Endocrinology (18)
  5. GSK Faculty (18)
  6. Human Oncology and Pathogenesis Program (18)

More Groups

People
  1. James Fagin (18)
  2. Mahesh Saqcena (10)
  3. Jeffrey Knauf (9)
  4. Ronald Ghossein (8)
  5. Alan Ho (7)
  6. Bin Xu (5)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (4)
  4. 2022 (4)
  5. 2021 (2)
  6. 2019 (1)

More Years

Publications
  1. Cancer Research (3)
  2. Cancer Discovery (2)
  3. Journal of Clinical Investigation (2)
  4. Annals of Oncology (1)
  5. Cancer Cell (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. Nature Publishing Group (3)
  3. American Society for Clinical Investigation (2)
  4. American Society of Clinical Oncology (1)
  5. Biomed Central Ltd (1)
  6. Bioscientifica Ltd (1)

More Publishers

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PTEN loss-of-function mutations prevalent in HRAS-mutant cancers results in resistance to targeted therapy
    Meeting Abstract

    Nigam, A.; Chatila, W. K.; Krishnamoorthy, G. P.; Ho, A. L.; Fagin, J. A.; Schultz, N. D.; Untch, B. R.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors
    Journal Article

    Garcia-Rendueles, M. E. R.; Krishnamoorthy, G.; Saqcena, M.; AcunĖƒa-Ruiz, A.; Revilla, G.; de Stanchina, E.; Knauf, J. A.; Lester, R.; Xu, B.; Ghossein, R. A.; more...
    Molecular Cancer (2022)

    Fulltext@MSK | Save
  • Co-inhibition of SMAD and MAPK signaling enhances (124)I uptake in BRAF-mutant thyroid cancers
    Journal Article

    Luckett, K. A.; Cracchiolo, J. R.; Krishnamoorthy, G. P.; Leandro-Garcia, L. J.; Nagarajah, J.; Saqcena, M.; Lester, R.; Im, S. Y.; Zhao, Z.; Lowe, S. W.; more...
    Endocrine-Related Cancer (2021)

    Fulltext@MSK | Save
  • SWI/SNF complex mutations promote thyroid tumor progression and insensitivity to redifferentiation therapies
    Journal Article

    Saqcena, M.; Leandro-Garcia, L. J.; Maag, J. L. V.; Tchekmedyian, V.; Krishnamoorthy, G. P.; Tamarapu, P. P.; Tiedje, V.; Reuter, V.; Knauf, J. A.; de Stanchina, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • EIF1AX and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC
    Journal Article

    Krishnamoorthy, G. P.; Davidson, N. R.; Leach, S. D.; Zhao, Z.; Lowe, S. W.; Lee, G.; Landa, I.; Nagarajah, J.; Saqcena, M.; Singh, K.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Tipifarnib inhibits HRAS-driven dedifferentiated thyroid cancers
    Journal Article

    Untch, B. R.; Dos Anjos, V.; Garcia-Rendueles, M. E. R.; Knauf, J. A.; Krishnamoorthy, G. P.; Saqcena, M.; Bhanot, U. K.; Socci, N. D.; Ho, A. L.; Ghossein, R.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Sustained ERK inhibition maximizes responses of Braf(V600E) thyroid cancers to radioiodine
    Journal Article

    Nagarajah, J.; Le, M.; Knauf, J. A.; Ferrandino, G.; Montero-Conde, C.; Pillarsetty, N.; Bolaender, A.; Irwin, C.; Krishnamoorthy, G. P.; Saqcena, M.; more...
    Journal of Clinical Investigation (2016)

    Fulltext@MSK | Save
  • Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
    Journal Article

    Landa, I.; Ibrahimpasic, T.; Boucai, L.; Sinha, R.; Knauf, J. A.; Shah, R. H.; Dogan, S.; Ricarte-Filho, J. C.; Krishnamoorthy, G. P.; Xu, B.; more...
    Journal of Clinical Investigation (2016)

    Fulltext@MSK | Save